KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
105 hedge funds and large institutions have $727M invested in Chinook Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 103 → 105 (+2)
3% more capital invested
Capital invested by funds: $707M → $727M (+$20.3M)
Holders
105
Holding in Top 10
7
Calls
$1.02M
Puts
$204K
Top Buyers
| 1 | +$16.9M | |
| 2 | +$14M | |
| 3 | +$11.3M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$9.48M |
| 5 |
Millennium Management
New York
|
+$6.33M |
Top Sellers
| 1 | -$38.7M | |
| 2 | -$29.4M | |
| 3 | -$18M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.3M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.87M |